Werewolf Therapeutics Files Proxy Statement
Ticker: HOWL · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1785530
| Field | Detail |
|---|---|
| Company | Werewolf Therapeutics, Inc. (HOWL) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
Related Tickers: WWR
TL;DR
Werewolf Therapeutics (WWR) proxy filed. Vote your shares!
AI Summary
Werewolf Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for its annual meeting on June 12, 2025. The filing outlines the company's governance and executive compensation details. Key proposals will likely include the election of directors and ratification of independent auditors.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership and voting matters, enabling informed participation in corporate governance decisions.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing detailing corporate governance and executive compensation, not a material event like an acquisition or earnings miss.
Key Players & Entities
- Werewolf Therapeutics, Inc. (company) — Registrant
- 0001140361-25-015885 (filing_id) — Accession Number
- 20250428 (date) — Filing Date
- 20250612 (date) — Meeting Date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with the proxy statement for the company's annual meeting, detailing information about the election of directors, executive compensation, and other corporate governance matters.
When is the shareholder meeting for which this proxy statement is being filed?
The shareholder meeting is scheduled for June 12, 2025.
Who is the filer of this document?
The filer of this document is Werewolf Therapeutics, Inc.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's business address?
The company's business address is 200 Talcott Avenue, 2nd Floor, Watertown, MA 02472.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Werewolf Therapeutics, Inc. (HOWL).